Synovial Sarcoma — Symptoms, Diagnosis & Treatment

What Is Synovial Sarcoma?

Synovial sarcoma is a rare but aggressive type of soft tissue cancer. The name is a historical accident — under the microscope its cells looked, to early pathologists, a little like the lining of a joint (the synovium), so it was called "synovial." In reality it does not arise from the joint lining and can appear far from any joint at all. What truly defines it is a specific genetic change rather than where it sits in the body.

It belongs to the broader family of soft tissue sarcomas — cancers of the connective tissues such as muscle, fat, tendon and the cells around blood vessels and nerves. You can read how the whole family is investigated and treated on our sarcoma — overview hub. What sets synovial sarcoma apart from most other sarcoma subtypes is the age group it strikes: while many sarcomas are diseases of older adults, synovial sarcoma has a clear peak in younger people, which is why it is so important to take a persistent lump in a young person seriously.

Why Does Synovial Sarcoma Affect Young Adults?

Synovial sarcoma is one of the most common soft tissue sarcomas in adolescents and young adults, with most cases diagnosed between the ages of 15 and 40. This is unusual — cancer in this age band is rare, and that very rarity is part of the danger. A 24-year-old with a firm lump on the thigh is far more likely to be told it is a pulled muscle, a ganglion, or a sports cyst than to be sent for an MRI. Weeks or months can pass before the diagnosis is even considered.

This is exactly the trap our page on sarcoma in adolescents & young adults (AYA) is written to break. Young people are fit, busy and used to aches that settle on their own, so a slowly enlarging lump is easy to ignore or to attribute to the gym. The rule that matters: any lump that is deep, firm, larger than a golf ball (about 5 cm), or growing — even slowly, even painlessly — needs imaging and, if suspicious, a biopsy. It does not matter how young or healthy you are.

• A lump that keeps growing over weeks or months, however slowly.
• A deep, firm lump you cannot easily move under the skin.
• Any lump bigger than 5 cm, regardless of pain.
• A lump that aches, or causes numbness or tingling if it presses on a nerve.

Synovial Sarcoma in the Leg and Near Joints

The large majority of synovial sarcomas — roughly two in three — develop in the limbs, and most of all in the leg: the thigh, around the knee, the lower leg, the ankle and the foot. They have a particular tendency to sit near large joints, which is part of how the misleading "synovial" name arose. A synovial sarcoma in the leg often presents as a deep lump close to the knee or in the back of the thigh, sometimes felt only as a firmness or fullness before it becomes an obvious mass.

Less commonly, synovial sarcoma can arise in the arm, the trunk, the head and neck region, or even the chest and abdomen. Because the leg is the commonest site, and because the leg is where people most easily blame the gym or a sprain, a leg lump in a young adult should never be brushed off. When it is caught early and is small, the chance of clearing it completely with limb-sparing surgery is much higher than when it has been left to grow for months.

How Synovial Sarcoma Is Diagnosed

Diagnosing synovial sarcoma accurately matters enormously, because the treatment is quite different from that of a benign lump or a more common cancer. At CION the diagnosis is built in a deliberate sequence, and crucially the biopsy is planned with the surgeon so the needle track can later be removed with the tumour.

Step 1 — MRI of the Affected Limb

MRI is the imaging investigation of choice for any suspected soft tissue sarcoma. It shows the exact size and depth of the lump and its relationship to nearby muscle, fascia, blood vessels, nerves and bone. For a young adult with a deep, growing leg lump, an MRI is the single most useful test — it can immediately flag features that point away from a simple cyst and toward a sarcoma.

Step 2 — Core Needle Biopsy

A small core of tissue is taken with a needle, under imaging guidance, so a specialist sarcoma pathologist can examine the cells. Whole-lump removal ("excisional biopsy") before the diagnosis is known is discouraged for suspected sarcoma, because it can compromise later margin-clear surgery. The needle is positioned along a line the surgeon can excise later.

Step 3 — Molecular Confirmation (the SS18-SSX Gene Fusion)

This is what makes synovial sarcoma unique. Nearly every synovial sarcoma carries a characteristic genetic change called the SS18-SSX gene fusion, caused by a swap of material between chromosomes X and 18 (the t(X;18) translocation). Molecular tests such as FISH or RT-PCR can detect this fusion in the biopsy and confirm the diagnosis with a high degree of certainty — settling cases where the appearance under the microscope is ambiguous. A confirmed SS18-SSX fusion is, in effect, the fingerprint of synovial sarcoma.

Step 4 — Staging Scans

Once the diagnosis is confirmed, a CT scan of the chest is done to check the lungs — the most common site to which synovial sarcoma can spread — and the case is then taken to the tumour board, where surgery, radiation and medical oncology agree the plan together.

How Synovial Sarcoma Is Treated

Synovial sarcoma is treated by combining three modalities, sequenced by the tumour board according to the tumour's size, grade and site. The great majority of limb tumours are treated with limb-sparing surgery — amputation is rarely needed today.

Because synovial sarcoma is more chemo-sensitive than many other sarcomas, the role of chemotherapy for sarcoma is taken seriously in larger and high-grade cases, rather than being treated as an afterthought. The right sequence — whether chemo or radiation comes before surgery, and whether systemic treatment is needed at all — is exactly the decision a multidisciplinary tumour board exists to make, and it should be made before the first operation, not after.

Prognosis and What Influences It

The outlook for synovial sarcoma depends heavily on how early it is caught and treated. The factors that most influence the outcome are the size of the tumour (smaller tumours, particularly those under 5 cm, do better), whether it has spread beyond its original site, the surgical margin achieved at operation, and the patient's age and general fitness. Younger patients with small, completely removed tumours can do well, which is why prompt diagnosis and expert surgery are worth pursuing energetically.

Two points are particular to this subtype. First, synovial sarcoma is more chemo-responsive than most sarcomas, which gives an extra treatment lever for larger or spread disease. Second, it can recur late — sometimes many years on — so surveillance does not stop at five years. Treatment at a centre that runs a structured, long-term follow-up programme is part of getting the best result. You can read about the wider service on our sarcoma treatment in Hyderabad page, and meet the team on our best sarcoma doctors in Hyderabad page.

Indicative Cost in Hyderabad

Costs are indicative. A personalised estimate is provided after your CION consultation. EMI options and cashless support through major TPAs, Aarogyasri, CGHS, ECHS & ESI are available for eligible patients.

Why Patients Choose CION for Synovial Sarcoma

Synovial sarcoma is rare, young-adult, and demands a coordinated three-way plan. Here is why patients trust CION to get it right from the first step.

Don't Wait on a Growing Lump

In synovial sarcoma, early diagnosis and an expert first operation change everything. If you or someone young in your family has a deep, growing lump — especially in the leg — talk to our sarcoma team first.